- Home
- ALVR vs CNTY Comparison
ALVR vs CNTY Comparison
Compare ALVR & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- CNTY
- Stock Information
- Founded
- ALVR 2013
- CNTY 1992
- Country
- ALVR United States
- CNTY United States
- Employees
- ALVR N/A
- CNTY N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- CNTY Hotels/Resorts
- Sector
- ALVR Health Care
- CNTY Consumer Discretionary
- Exchange
- ALVR Nasdaq
- CNTY Nasdaq
- Market Cap
- ALVR 87.7M
- CNTY 81.6M
- IPO Year
- ALVR 2020
- CNTY 1993
- Fundamental
- Price
- ALVR $0.94
- CNTY $3.37
- Analyst Decision
- ALVR Sell
- CNTY Buy
- Analyst Count
- ALVR 5
- CNTY 3
- Target Price
- ALVR $1.00
- CNTY $4.00
- AVG Volume (30 Days)
- ALVR 155.6K
- CNTY 53.0K
- Earning Date
- ALVR 11-04-2024
- CNTY 11-04-2024
- Dividend Yield
- ALVR N/A
- CNTY N/A
- EPS Growth
- ALVR N/A
- CNTY N/A
- EPS
- ALVR N/A
- CNTY N/A
- Revenue
- ALVR N/A
- CNTY $587,389,000.00
- Revenue This Year
- ALVR N/A
- CNTY $10.03
- Revenue Next Year
- ALVR N/A
- CNTY $9.31
- P/E Ratio
- ALVR N/A
- CNTY N/A
- Revenue Growth
- ALVR N/A
- CNTY 27.26
- 52 Week Low
- ALVR $0.58
- CNTY $1.94
- 52 Week High
- ALVR $2.49
- CNTY $5.06
- Technical
- Relative Strength Index (RSI)
- ALVR 69.10
- CNTY 75.08
- Support Level
- ALVR $0.74
- CNTY $2.75
- Resistance Level
- ALVR $0.91
- CNTY $2.75
- Average True Range (ATR)
- ALVR 0.06
- CNTY 0.15
- MACD
- ALVR 0.01
- CNTY 0.06
- Stochastic Oscillator
- ALVR 94.50
- CNTY 100.00
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurant, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.